Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2572021017 | Dantron + poloxamer strong 75mg/1000mg/5mL oral suspension (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2576009018 | Dantron + poloxamer strong 75mg/1000mg/5mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2576010011 | Co-danthramer strong 75mg/1000mg/5mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3128591000052111 | dantron 75 mg/5 ml + poloxamer, stark 1 000 mg/5 ml, oral suspension | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| dantron 75 mg/5 ml + poloxamer, stark 1 000 mg/5 ml, oral suspension | Is a | Product containing dantron and poloxamer 188 (medicinal product) | false | Inferred relationship | Some | ||
| dantron 75 mg/5 ml + poloxamer, stark 1 000 mg/5 ml, oral suspension | Has active ingredient | Dantron | false | Inferred relationship | Some | ||
| dantron 75 mg/5 ml + poloxamer, stark 1 000 mg/5 ml, oral suspension | Has active ingredient | Anthraquinone laxative (substance) | false | Inferred relationship | Some | ||
| dantron 75 mg/5 ml + poloxamer, stark 1 000 mg/5 ml, oral suspension | Has manufactured dose form | Oral suspension | false | Inferred relationship | Some | ||
| dantron 75 mg/5 ml + poloxamer, stark 1 000 mg/5 ml, oral suspension | Has active ingredient | Poloxamer 188 (substance) | false | Inferred relationship | Some | ||
| dantron 75 mg/5 ml + poloxamer, stark 1 000 mg/5 ml, oral suspension | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR